All News #Library
Rare Diseases
Menarini partners VisualDx to Identify Blastic Plasmacytoid Cell BPDCN
20 Mar 2025 //
GLOBENEWSWIRE
The Menarini Group Announces ELZONRIS Designated as an Orphan Drug for BPDCN
30 Aug 2023 //
BUSINESSWIRE

Market Place
Sourcing Support